All In Biotech

Free tool

FAERS Monitor: Velcade

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021602 or its brand name (Velcade, Bortezomib). Reports on generic versions are filed under their own applications.

Reports

89,988

Serious

75,667

84% of reports

Hospitalization

28,650

Death reported

14,182

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • plasma cell myeloma9,241
  • neuropathy peripheral6,529
  • off label use6,498
  • diarrhoea5,237
  • fatigue4,581
  • death4,220
  • pneumonia4,108
  • drug ineffective3,816
  • thrombocytopenia3,761
  • nausea3,129
  • pyrexia2,898
  • neutropenia2,749
  • anaemia2,718
  • rash2,472
  • disease progression2,458

Reports by year received

View as table
YearReports
2004486
2005906
2006949
2007930
20081,285
20091,463
20101,604
20112,045
20123,007
20132,560
20142,551
20158,052
20164,697
20174,756
20185,415
20196,400
20207,052
20217,529
20227,188
20236,712
20245,857
20254,910
20263,634

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,964,171 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
plasma cell myelomaSignal9,24172.270.6496,249
neuropathy peripheralSignal6,52917.116.792,890
thrombocytopeniaSignal3,7618.17.822,732
disease progressionSignal2,4584.94.77,596
neutropeniaSignal2,7494.84.68,158
anaemiaSignal2,7183.43.24,491
pneumoniaSignal4,1083.02.95,457
pyrexia2,8982.01.91,385
diarrhoea5,2371.91.92,298
off label use6,4981.71.72,117
fatigue4,5811.41.3489
rash2,4721.31.3202
death4,2201.11.181
nausea3,1290.90.920
drug ineffective3,8160.70.7631

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.